Manda Wong

458 total citations
7 papers, 147 citations indexed

About

Manda Wong is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Manda Wong has authored 7 papers receiving a total of 147 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Surgery. Recurrent topics in Manda Wong's work include Monoclonal and Polyclonal Antibodies Research (3 papers), Eosinophilic Esophagitis (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Manda Wong is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), Eosinophilic Esophagitis (2 papers) and IL-33, ST2, and ILC Pathways (2 papers). Manda Wong collaborates with scholars based in United States, United Kingdom and France. Manda Wong's co-authors include Racquel Corpuz, James A. Ernst, Gauri Deshmukh, Travis W. Bainbridge, Noelyn M. Kljavin, Justin Q. Ly, Diana Dunshee, Daniel P. Sutherlin, Amy C. Schroeder and Ruby L.Y. Chan and has published in prestigious journals such as Journal of Biological Chemistry, American Journal of Respiratory and Critical Care Medicine and Investigative Ophthalmology & Visual Science.

In The Last Decade

Manda Wong

7 papers receiving 142 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manda Wong United States 4 98 36 25 22 20 7 147
Claudia Lentucci United States 5 102 1.0× 18 0.5× 25 1.0× 9 0.4× 20 1.0× 6 142
Pedro Oliveira United Kingdom 6 72 0.7× 34 0.9× 13 0.5× 13 0.6× 28 1.4× 14 155
Anastasia I. Kousa United States 6 138 1.4× 37 1.0× 28 1.1× 4 0.2× 13 0.7× 11 196
Melanie Börries Germany 6 155 1.6× 15 0.4× 27 1.1× 7 0.3× 33 1.6× 11 211
Miriam Bertrand Germany 6 61 0.6× 51 1.4× 20 0.8× 7 0.3× 40 2.0× 14 143
Yuman He China 8 92 0.9× 41 1.1× 29 1.2× 6 0.3× 58 2.9× 12 178
Evangeline Reynolds United States 4 75 0.8× 44 1.2× 16 0.6× 6 0.3× 39 1.9× 5 126
John Chionis United States 6 105 1.1× 36 1.0× 9 0.4× 14 0.6× 9 0.5× 11 144
Zhiqin Huang China 9 135 1.4× 16 0.4× 11 0.4× 14 0.6× 15 0.8× 20 186
Saya H. Ebbesen United States 3 90 0.9× 45 1.3× 13 0.5× 7 0.3× 23 1.1× 3 123

Countries citing papers authored by Manda Wong

Since Specialization
Citations

This map shows the geographic impact of Manda Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manda Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manda Wong more than expected).

Fields of papers citing papers by Manda Wong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manda Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manda Wong. The network helps show where Manda Wong may publish in the future.

Co-authorship network of co-authors of Manda Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Manda Wong. A scholar is included among the top collaborators of Manda Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manda Wong. Manda Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Wong, Manda, et al.. (2025). Structural Basis for Inhibition of IL-33 Induced ST2 Activation by Astegolimab. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A6895–A6895. 1 indexed citations
2.
Tsai, Wen‐Ting K., Yinyin Li, Zhaojun Yin, et al.. (2024). Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG 1 antibodies. mAbs. 16(1). 2362789–2362789. 7 indexed citations
3.
Tran, Peter, Justin Low, Manda Wong, et al.. (2022). Introducing Dendritic Cell Antibody Internalization as an Immunogenicity Risk Assessment Tool. Bioanalysis. 14(10). 703–713. 10 indexed citations
4.
Mai, Elaine, Braeden K. Ego, Jack Bevers, et al.. (2021). Development of an ultra-sensitive human IL-33 biomarker assay for age-related macular degeneration and asthma drug development. Journal of Translational Medicine. 19(1). 517–517. 3 indexed citations
5.
Huang, Tao, Mary Mathieu, Sophia Lee, et al.. (2017). Molecular characterization of human anti-hinge antibodies derived from single-cell cloning of normal human B cells. Journal of Biological Chemistry. 293(3). 906–919. 8 indexed citations
6.
Dunshee, Diana, Travis W. Bainbridge, Noelyn M. Kljavin, et al.. (2016). Fibroblast Activation Protein Cleaves and Inactivates Fibroblast Growth Factor 21. Journal of Biological Chemistry. 291(11). 5986–5996. 117 indexed citations
7.
Loyet, Kelly M., Manda Wong, Alyssa Morimoto, et al.. (2010). Anti-Factor D Fab Specifically Inhibits the Alternative Complement Pathway: In vitro Characterization and in vivo Effects Following Administration to Cynomolgus Monkeys. Investigative Ophthalmology & Visual Science. 51(13). 2980–2980. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026